Hye Lin Park

Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors

Sukjoong Oh, Y. Do, Joon Seong Park, 2014, Haematologica.

Optimization of radotinib doses for the treatment of Asian patients with chronic myelogenous leukemia based on dose-response relationship analyses

Sukjoong Oh, D. Cho, Dong-Wook Kim, 2016, Leukemia & lymphoma.

Determination of a radotinib dosage regimen based on dose–response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia

Dae Jin Jo, Sukjoong Oh, Y. Do, 2018, Cancer medicine.

Efficacy and Safety of Radotinib in Chronic Phase Chronic Myeloid Leukemia Patients with Resistance or Intolerance to BCR-ABL Tyrosine Kinase Inhibitors: Radotinib Phase 2 Clinical Trial

Sukjoong Oh, Joon Seong Park, G. Lee, 2012 .

Comparisons of the Mucosal Healing Process between Flat and Protruded Type after Endoscopic Submucosal Dissection for Gastric Neoplasms

S. Shin, J. Hwang, B. Yoo, 2019, Digestion.

Impact of Body Weight Adjusted Dose on Efficacy and Safety of Radotinib in Chronic Myeloid Leukemia

Dae Jin Jo, Sukjoong Oh, Y. Do, 2016 .